Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Stereotactic Body Radiation Therapy
82%
Overall Survival
57%
Local Control
49%
Non-small Cell Lung Cancer (NSCLC)
27%
Institutional Experience
25%
RelB
25%
Astrocytes
23%
Biologically Effective Dose
23%
Sphingosine-1-phosphate
20%
Sphingosine Kinase 1 (SphK1)
18%
Local Failure
17%
Survival Outcomes
16%
Glioblastoma multiforme
16%
Ovarian Cancer
16%
Large Language Models
16%
Chemoradiotherapy
16%
Interleukin-1β
16%
Spine
16%
Prostate
15%
Lymph Node
15%
Local Recurrence-free Survival
14%
Kaplan-Meier Method
14%
Radiation Oncologist
13%
Breast Cancer
11%
Univariate Analysis
10%
Yin-Yang
10%
Salvage Treatment
10%
Metastatic Breast Cancer
10%
Inflammation
10%
Progression-free Survival
10%
Molecular Switches
9%
Cell Proliferation
9%
Recurrent Non-small Cell Lung Cancer
9%
Median Overall Survival
9%
Pulmonary Lesions
9%
Radiotherapy
9%
Sterile Inflammation
9%
Glioblastoma multiforme Cells
9%
After Surgery
9%
Metastasis
8%
Exclusion Criteria
8%
Organs at Risk
8%
Inter-fraction
8%
Target Coverage
8%
Oligodendrocyte Maturation
8%
Stromal Reprogramming
8%
Whole Pelvic Radiotherapy
8%
Whole Pelvic Radiation Therapy
8%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
8%
Spinal Metastasis
8%
Medicine and Dentistry
Stereotactic Body Radiation Therapy
100%
Overall Survival
57%
Radiation Therapy
37%
Non Small Cell Lung Cancer
37%
Progression Free Survival
26%
Kaplan Meier Method
23%
Lymph Node
18%
Low Drug Dose
17%
Prostate Cancer
16%
Lung Lesion
16%
Metastatic Carcinoma
16%
Diseases
15%
Recurrent Disease
15%
Malignant Neoplasm
13%
Neoplasm
12%
Proportional Hazards Model
12%
Adaptive Radiation
11%
Univariate Analysis
11%
Bladder
11%
Artificial Intelligence
11%
Tumor
11%
Lung
10%
Pelvis
10%
Radiation Oncologist
10%
Pancreas Adenocarcinoma
9%
Primary Tumor
9%
Alanine Aminotransferase
8%
Sleep Disorder
8%
Pelvic Radiotherapy
8%
Spinal Cord Metastasis
8%
Squamous Cell Carcinoma
8%
Transitional Cell Carcinoma
8%
Chemoradiotherapy
8%
Adaptive Radiotherapy
8%
Liver Metastasis
8%
Ovarian Cancer
8%
Prognostic Factor
8%
Spine Metastasis
8%
Recursive Partitioning
8%
Stereotactic Radiosurgery
8%
Pancreas Tumor
8%
Histology
8%
Magnetic Resonance Imaging
8%
Chemotherapy
8%
Adenocarcinoma
7%
Predictive Factor
6%
Hazard Ratio
6%
Median Follow Up
6%
Risk Stratification
5%
